Clinical guidelines for the diagnosis and management of pediatric fecal incontinence: A comprehensive review and treatment algorithm

Abstract

Pediatric fecal incontinence (FI) is a multifactorial condition with functional, neurodevelopmental, and organic etiologies. Despite its prevalence, FI remains underdiagnosed, stigmatized, and associated with significant psychosocial and family burden. This review synthesizes current evidence on the diagnosis, pathophysiology, and management of pediatric FI and proposes practical, algorithm-based guidance for frontline clinicians and subspecialists. A structured literature search of PubMed, Scopus, and Cochrane databases was conducted, focusing on pediatric FI, functional and organic subtypes, neurodevelopmental comorbidities, and multidisciplinary interventions. Emphasis was placed on evidence-based management strategies, emerging therapeutic innovations, and psychosocial considerations. Functional retentive FI often responds to structured disimpaction, maintenance laxatives, and behavioral interventions, whereas non-retentive forms require tailored psychological and behavioral therapies. Organic etiologies often require long-term, multidisciplinary care, surgical intervention, or neuromodulation. Special populations—including children with autism spectrum disorder, attention-deficit/hyperactivity disorder, developmental delay, and postoperative anorectal conditions—require individualized, developmentally adapted programs. Psychosocial impacts on children and families are significant and require coordinated counseling. Emerging research highlights the gut-brain axis, microbiome modulation, digital behavioral applications, and precision bowel management as future directions. Limitations include heterogeneous study designs, lack of long-term pediatric randomized controlled trials, and variable outcome measures. Pediatric FI is a complex condition requiring early recognition, subtype-specific management, and multidisciplinary care. Algorithm-based, individualized strategies that integrate physiological, behavioral, and psychosocial components optimize long-term continence, psychosocial well-being, and quality of life. Future research should focus on standardized outcomes, neuromodulatory interventions, and precision, technology-enhanced therapies.

Key Words: Pediatric fecal incontinence; Encopresis; Functional constipation; Non-retentive fecal incontinence; Neurodevelopmental disorders; Gut-brain axis; Multidisciplinary management; Bowel programs

Core Tip: Pediatric fecal incontinence is a multifactorial disorder with functional, neurodevelopmental, and organic causes. Early recognition, accurate subtype differentiation, and structured, individualized bowel programs are essential for optimal outcomes. Functional retentive forms respond to disimpaction, maintenance laxatives, and behavioral strategies, whereas non-retentive and neurodevelopmentally complex cases require psychological interventions and caregiver-guided routines. Organic etiologies often require long-term, multidisciplinary care, surgical intervention, or neuromodulation. Psychosocial burden on children and families is significant and must be addressed. Emerging approaches—including gut-brain axis modulation, microbiome-targeted therapies, and digital behavioral platforms—promise precision, personalized care, and improved long-term quality of life.

INTRODUCTION

Pediatric fecal incontinence (FI) represents a common yet frequently underestimated clinical problem in childhood. According to the Rome IV criteria, functional FI (FFI) is defined as the repeated passage of stool in inappropriate places (e.g., clothing or floor), whether involuntary or intentional, occurring at least once per month for a minimum of two months in a child with a developmental age of at least four years, in the absence of an underlying organic condition[1]. The Rome IV classification further distinguishes between functional retentive FI (FRFI) and non-retentive FI (NRFI), emphasizing the central role of stool retention and rectal dysfunction in most affected children. This standardized definition has improved diagnostic consistency; however, variability in clinical recognition persists[2].

Epidemiologically, pediatric FI affects approximately 1%-4% of school-aged children worldwide, with a higher prevalence in boys. Although the incidence decreases with age, a significant subset of patients continues to experience symptoms into adolescence if not appropriately managed. Importantly, most cases are functional and related to chronic constipation, yet organic etiologies—including neurogenic bowel, anorectal malformations (ARMs), and Hirschsprung disease—must be carefully excluded. The global burden of disease is likely underestimated due to underreporting, cultural sensitivities, and inconsistent access to healthcare across regions[3].

Beyond its physical manifestations, FI exerts a profound psychosocial impact. Affected children often experience embarrassment, social withdrawal, bullying, and diminished self-esteem. School participation may be compromised, and anxiety surrounding accidents can interfere with academic performance[4]. Families frequently report frustration, guilt, and strained parent-child relationships, particularly when symptoms are misinterpreted as behavioral misconduct rather than a medical disorder. The chronicity of untreated constipation and recurrent soiling episodes may create a cycle of blame and punitive responses, further exacerbating emotional distress[5,6].

Despite its prevalence and consequences, pediatric FI remains underdiagnosed and undertreated. Contributing factors include stigma, reluctance of families to disclose symptoms, limited time during clinical encounters, and variability in physician training regarding functional gastrointestinal disorders. Moreover, the absence of a universally applied stepwise clinical pathway often leads to fragmented care, unnecessary investigations, delayed initiation of treatment, or premature referral to subspecialists. Inconsistent practices may also contribute to therapeutic failure and relapse[1].

Over the past decade, advances in understanding anorectal physiology, behavioral mechanisms, and long-term management strategies have refined the approach to pediatric FI. However, existing recommendations are often dispersed across constipation guidelines, surgical literature, and subspecialty consensus statements. There remains a need for an integrated, clinically pragmatic framework that consolidates diagnostic criteria, red flag identification, evidence-based treatment phases, and escalation strategies into a coherent algorithm suitable for both primary care pediatricians and subspecialists[7,8].

The objective of this review is to provide a comprehensive, evidence-based synthesis of current knowledge regarding the diagnosis and management of pediatric FI, integrating contemporary definitions, pathophysiological insights, and therapeutic strategies into a clear, clinically applicable framework. Particular emphasis is placed on differentiating functional from organic etiologies, identifying red flags that warrant further investigation, and outlining a structured, stepwise treatment approach. The review aims to translate the available evidence into a practical diagnostic and therapeutic algorithm to support consistent, high-quality care in both primary and subspecialty pediatric settings. This review goes beyond traditional narrative summaries by proposing a unified, algorithm-based clinical framework that combines pathophysiological mechanisms with behavioral and psychosocial factors of pediatric FI. It advances the field by framing FI within a biopsychosocial continuum, connecting rectal dysfunction, neurodevelopmental aspects, and environmental influences into a single decision-making model. Additionally, the review presents a risk-stratified, phenotype-driven management approach that prioritizes early differentiation among retentive, non-retentive, and organic forms to enable targeted therapy. These conceptual integrations aim to close the gap between evidence synthesis and practical clinical application.

METHODOLOGY

This narrative review was conducted using a structured literature search to synthesize current evidence on the diagnosis and management of pediatric FI, including functional, neurodevelopmental, and organic etiologies.

Literature search strategy

A comprehensive search of three major electronic databases (PubMed/MEDLINE, Scopus, and the Cochrane Library) was conducted to identify relevant literature published between January 2000 and December 2025, ensuring the inclusion of both foundational and contemporary evidence. The search strategy integrated medical subject headings with free-text terms, combined using Boolean operators. Key terms included “pediatric fecal incontinence”, “childhood fecal incontinence”, “functional fecal incontinence”, “non-retentive fecal incontinence”, “functional constipation”, “fecal incontinence”, “encopresis”, “neurogenic bowel”, “anorectal malformations”, “Hirschsprung disease”, “gut-brain axis”, “bowel dysfunction”, “microbiome”, “constipation”, “behavioral therapy”, and “toileting disorders”. Example Boolean combinations used were (“fecal incontinence” AND “pediatric”) AND (“functional” OR “organic” OR “neurogenic”) and (“constipation” AND “children”) AND (“behavioral therapy” OR “laxatives”). Additionally, reference lists of relevant articles and key reviews were manually screened to identify further pertinent studies.

Inclusion and exclusion criteria

Inclusion criteria: The inclusion criteria encompassed studies involving children and adolescents aged 0-18 years, including clinical trials, observational studies, systematic reviews, and high-quality narrative reviews. Eligible articles addressed the pathophysiology, diagnosis, management, or psychosocial aspects of FI and included research on functional, non-retentive, neurodevelopmental, and organic causes.

Exclusion criteria: Studies were excluded if they were limited to adult populations, consisted of case reports with limited generalizability, were published in languages other than English unless highly relevant and widely cited, or lacked clear clinical relevance to pediatric FI.

Data synthesis

Data were narratively synthesized and organized into key thematic domains, including classification, pathophysiology, diagnostic approach, management strategies, psychosocial impact, special populations, and emerging therapeutic directions. Particular emphasis was placed on clinically applicable evidence and the development of algorithm-based management frameworks to support decision-making in both primary and specialist care settings.

Evidence grading

Where applicable, evidence was categorized using a simplified hierarchy adapted from established evidence-based frameworks: (1) Level I: Randomized controlled trials (RCTs) or meta-analyses; (2) Level II: Prospective or controlled cohort studies; (3) Level III: Observational studies, retrospective analyses, or case series; and (4) Level IV: Expert opinion or consensus-based recommendations.

Scope and limitations

Given the narrative design, this review does not follow a formal systematic review protocol (e.g., PRISMA) and may be subject to selection bias. However, efforts were made to ensure comprehensive coverage and balanced representation of current evidence.

DEFINITIONS AND CLASSIFICATION

Accurate classification of pediatric FI is fundamental to appropriate management. Broadly, FI is categorized as functional or organic. Functional forms account for most cases in childhood, whereas organic causes, though less common, require timely identification to prevent complications and guide targeted therapy[9].

FFI

FFI is diagnosed when the Rome IV criteria are met, and no structural, metabolic, or neurological disorder accounts for the symptoms. It is subdivided into retentive and non-retentive types (Table 1 and Figure 1)[10].

Figure 1 Types of pediatric fecal incontinence. IBD: Inflammatory bowel disease.

Table 1 Comparative clinical features of different types of pediatric fecal incontinence.

Feature	Functional retentive	Functional non-retentive	Organic
Stool frequency	Infrequent	Normal	Variable
Stool consistency	Often hard, large caliber	Normal	Variable (maybe loose or obstructive)
Fecal impaction	Common	Absent	Variable
Rectal dilation	Common	Absent	Usually absent (except obstruction)
Withholding behavior	Common	Rare	Rare
Growth parameters	Normal	Normal	May be impaired
Neurological findings	Normal	Normal	May be abnormal
Systemic symptoms	Absent	Absent	May be present
Response to laxatives	Good	Limited	Variable/poor

This classification framework provides a structured foundation for the subsequent diagnostic algorithm, emphasizing that while most pediatric fecal incontinence is functional and constipation-related, careful assessment is essential to identify children who require further investigation for underlying organic pathology.

Retentive FI (associated with functional constipation; FRFI): FRFI is the most common subtype and typically results from chronic functional constipation. Repeated stool withholding—often triggered by painful defecation—leads to rectal fecal impaction, progressive rectal dilation, reduced rectal sensation, and overflow soiling. Children may pass large-caliber stools, experience infrequent bowel movements, and demonstrate classic withholding behaviors (e.g., stiffening, crossing legs). Over time, the distended rectum loses normal sensation, and soft stool leaks involuntarily around impacted fecal matter[11]. This subtype is primarily a disorder of stool retention and anorectal dysfunction rather than voluntary misconduct. Recognition of this pathophysiological mechanism is essential to avoid inappropriate behavioral labeling[12].

Non-retentive FFI (NRFI): NRFI occurs in children without evidence of constipation or fecal retention. Bowel movement frequency is typically normal, and stools are not hard or impacted. Pathogenesis is less clearly understood and may involve behavioral dysregulation, psychosocial stressors, or altered defecation dynamics. These children usually lack rectal dilation and do not exhibit significant stool withholding behaviors. Management often requires a stronger behavioral and psychological component compared with retentive FI[13].

Organic causes

Although less common, organic etiologies must be excluded, particularly in the presence of red flags (e.g., delayed meconium passage, poor growth, neurologic deficits, severe abdominal distension)[14].

Neurogenic bowel: Neurogenic bowel dysfunction results from impaired neural control of anorectal function due to abnormalities in the central or peripheral nervous system. It may be associated with cerebral palsy, spinal cord injury, or congenital spinal anomalies. These children often exhibit abnormal anal tone, impaired reflexes, and variable constipation or incontinence patterns[15].

ARMs: Congenital ARMs may present with persistent FI even after surgical correction. Altered sphincter anatomy, impaired innervation, or postoperative complications can contribute to chronic symptoms[16].

Hirschsprung disease: This congenital absence of enteric ganglion cells leads to functional intestinal obstruction. While classically presented in infancy, milder forms may be diagnosed later in childhood. Persistent constipation, abdominal distension, and failure to thrive should raise suspicion. Diagnosis requires histopathological confirmation via rectal biopsy[17].

Spinal dysraphism: Occult or overt spinal dysraphism—including tethered cord and spina bifida—may impair sacral innervation of the bowel. Cutaneous stigmata over the lumbosacral area or neurologic abnormalities should prompt further evaluation[18].

Celiac disease: Although primarily a malabsorptive disorder, celiac disease can present with constipation and, rarely, FI. Associated symptoms such as growth failure, anemia, or chronic diarrhea may coexist[19].

Inflammatory bowel disease: Inflammatory bowel disease may contribute to urgency, diarrhea, and occasional incontinence. Systemic features such as weight loss, abdominal pain, rectal bleeding, or elevated inflammatory markers help differentiate it from functional conditions[20].

PATHOPHYSIOLOGY

Understanding the pathophysiological mechanisms underlying pediatric FI is essential for rational, stepwise management. In most children, FI is functional and related to chronic constipation and rectal dysfunction. However, non-retentive and organic mechanisms involve distinct physiological and neurobehavioral pathways (Figure 2)[21].

Figure 2 Pathophysiological mechanisms of pediatric fecal incontinence. This schematic diagram illustrates the principal pathophysiological pathways leading to pediatric fecal incontinence (FI). Retentive mechanisms begin with painful defecation, leading to stool withholding, chronic fecal retention, rectal dilation (megarectum), impaired rectal sensation, and ultimately overflow incontinence. Non-retentive mechanisms are primarily related to behavioral and psychological factors that result in inconsistent toileting behavior and inappropriate stool passage in the absence of fecal retention. Neurogenic and structural causes involve sacral nerve dysfunction, sphincter impairment, or pelvic floor dyssynergia, leading to defective continence mechanisms. The figure emphasizes that although distinct mechanisms exist, all pathways converge on the final clinical manifestation of FI.

Retentive mechanisms

FRFI is primarily a consequence of chronic functional constipation, as defined by the Rome IV criteria. The disorder typically begins with painful defecation, leading to voluntary stool withholding. Over time, several interrelated physiological changes occurred[6].

Repeated withholding leads to prolonged fecal stasis and chronic rectal stool retention. Water absorption increases, stool becomes harder and larger, and defecation becomes increasingly painful, reinforcing the withholding cycle. Persistent accumulation of stool leads to progressive rectal distension and dilation (megarectum). The rectum adapts to increased volume, and its compliance rises abnormally. Chronic dilation blunts rectal sensory signaling, causing impaired rectal sensation[22]. The child no longer feels the normal urge to defecate until rectal filling is severe. This sensory impairment perpetuates retention. Soft or liquid stool from the proximal colon leaks around impacted fecal material and escapes involuntarily (overflow incontinence). This “overflow soiling” is often misinterpreted as diarrhea or behavioral misconduct, but it reflects underlying fecal impaction. Overall, retentive FI represents a self-perpetuating cycle: Pain—withholding—retention—rectal dilation—sensory impairment—overflow[1].

Non-retentive mechanisms

In NRFI, stool retention and rectal dilation are absent. The underlying mechanisms are less clearly defined and likely multifactorial. Some children demonstrate inappropriate toileting behaviors, irregular toilet use, or defecation in non-designated places without evidence of constipation (behavioral dysregulation). This may be associated with developmental delays or neurobehavioral conditions. Psychosocial stressors—such as family conflict, school difficulties, trauma, or anxiety—may contribute to altered toileting patterns[23]. Emotional dysregulation can interfere with normal defecation cues and routines. Unlike retentive FI, anorectal physiology is generally preserved. NRFI is therefore more strongly linked to behavioral and environmental factors than to mechanical obstruction or rectal dysfunction[24].

Neurogenic and structural causes

Organic causes involve disruption of neural control, sphincter anatomy, or anorectal coordination.

Sacral innervation abnormalities: Normal continence depends on intact sacral nerve pathways (S2-S4), which regulate internal and external anal sphincter tone and rectal sensation. Conditions such as spinal dysraphism, tethered cord, or cerebral palsy impair neural signaling, leading to reduced sphincter control and altered reflexes[15].

Pelvic floor dyssynergia: Dyssynergic defecation occurs when pelvic floor muscles paradoxically contract rather than relax during attempted defecation. This functional outlet obstruction may contribute to chronic constipation and secondary incontinence. In structural disorders, altered sphincter anatomy may further compromise continence[25]. In organic conditions such as Hirschsprung disease or postoperative ARMs, abnormal enteric innervation or sphincter integrity disrupts coordinated bowel evacuation[26].

Proposed conceptual hypothesis

We propose that pediatric FI represents a dynamic interaction between rectal dysfunction, altered gut-brain signaling, and behavioral modulation, rather than a purely mechanical or behavioral disorder. This integrated model suggests that effective management requires simultaneous targeting of physiological abnormalities, behavioral patterns, and psychosocial stressors, which may explain variability in treatment response across subtypes and patient populations.

DIAGNOSTIC APPROACH

A structured, clinically driven diagnostic approach is essential for differentiating FFI from organic etiologies, avoiding unnecessary investigations, and initiating timely management (Figure 3). In most cases, careful history and physical examination are sufficient to establish the diagnosis[27].

Figure 3 Investigative pathway for pediatric fecal incontinence. This figure illustrates a structured, stepwise diagnostic algorithm for children presenting with fecal incontinence (FI). The evaluation begins with comprehensive clinical history and physical examination to distinguish typical functional FI from cases with red flags or atypical features. In the absence of alarm signs, children are managed as functional FI with standard therapy and close monitoring of response. The presence of red flags (e.g., delayed meconium passage, severe abdominal distension, neurologic abnormalities, growth failure, refractory symptoms, or systemic features) prompts targeted investigations. These include rectal biopsy and/or contrast enema for suspected Hirschsprung disease; anorectal manometry and spinal magnetic resonance imaging for suspected neurogenic bowel; thyroid and celiac screening in the presence of growth or systemic concerns; and contrast imaging for suspected structural abnormalities. Failure to respond to appropriate management or identification of organic pathology warrants referral for specialized multidisciplinary or surgical evaluation. This algorithm emphasizes early identification of organic causes while minimizing unnecessary investigations in typical functional cases. FI: Fecal incontinence.

Clinical evaluation

A comprehensive and sensitive history remains the cornerstone of diagnosis. Because stigma and embarrassment frequently delay presentation, clinicians should create a nonjudgmental environment and address both the child and caregivers. The baseline bowel habits should be determined, including frequency, consistency (using the Bristol Stool Form Scale if appropriate), stool size, and episodes of soiling. Infrequent large-caliber stools strongly suggest functional constipation with retentive FI[28]. A history of painful or difficult bowel movements is highly suggestive of stool withholding and chronic constipation. Pain often represents the initiating event in the retentive cycle. Caregivers may describe characteristic posturing behaviors: Crossing, stiffening, hiding in corners, rocking, or clenching buttocks. These behaviors are often misinterpreted as attempts to defecate but actually reflect voluntary stool retention[29].

Pediatricians should look for red flags that may suggest an organic etiology. For example, delayed passage of meconium (> 48 hours after birth) raises concern for Hirschsprung disease. In addition, unintentional weight loss or poor growth may suggest systemic disease such as celiac disease or Inflammatory bowel disease. Neurologic deficits, including lower limb weakness, abnormal gait, or urinary incontinence, may indicate spinal pathology or neurogenic bowel. Additional important historical elements include age at symptom onset, toilet-training history, psychosocial stressors, dietary patterns, medication use, developmental status, and prior treatments[30,31].

Physical examination

A focused yet thorough physical examination complements the history and helps confirm functional constipation while screening for organic disease. Abdominal Examination may show abdominal distension, palpable fecal masses (particularly in the left lower quadrant), tenderness, or signs of obstruction. A firm, stool-filled colon supports a diagnosis of retentive FI[9]. Inspection of the perineal area may reveal fissures (suggesting painful defecation), erythema from chronic soiling, abnormal anal position, or signs of ARM. Perianal sensation and the presence of the anal wink reflex should be noted. Digital rectal examination (DRE) is not mandatory in every child, but should be performed when the diagnosis is uncertain, red flags are present, or stool impaction is suspected. Findings may include hard stool in the rectal vault, reduced anal tone, explosive stool on withdrawal (suggestive of Hirschsprung disease), or abnormal sphincter tone[32]. A brief but targeted neurologic assessment should include lower-limb tone and strength, deep tendon reflexes, gait, and inspection of the lumbosacral region for cutaneous stigmata (e.g., sacral dimple, tuft of hair, lipoma), which may indicate occult spinal dysraphism. In most children, a detailed history and physical examination are sufficient to establish a diagnosis of FFI. Further investigations should be reserved for atypical presentations or for cases in which organic pathology is suspected, as outlined in the subsequent section[1].

Red flags suggesting organic etiology

Although most cases of pediatric FI are functional, clinicians must remain vigilant for features suggestive of underlying organic disease. The presence of any of the following findings should prompt further diagnostic evaluation and, when appropriate, referral to pediatric gastroenterology or pediatric surgery. Table 2 summarizes the red flags that may indicate an underlying organic cause of pediatric FI[29]. Identifying these red flags shifts the diagnostic strategy from a presumptive functional diagnosis to a targeted investigation aimed at excluding structural, neurologic, metabolic, or inflammatory disorders. In their absence, and when clinical features are consistent with functional constipation, extensive testing is generally unnecessary[27].

Table 2 Red flags suggesting organic etiology in pediatric fecal incontinence.

Category	Red flags
Neonatal and early-onset features	Delayed passage of meconium (> 48 hours after birth); onset of severe constipation in infancy (< 1 year of age); persistent abdominal distension since early infancy
Growth and systemic concerns	Failure to thrive or unexplained weight loss; delayed puberty; chronic fatigue, anemia, or systemic inflammatory signs
Gastrointestinal alarm symptoms	Bilious vomiting; severe abdominal distension; recurrent rectal bleeding (not attributable to fissures); persistent diarrhea with incontinence; explosive stool on digital rectal examination (suggestive of Hirschsprung disease)
Neurologic abnormalities	Lower limb weakness or hypotonia; abnormal deep tendon reflexes; abnormal gait; urinary incontinence or recurrent urinary tract infections; absent anal wink or decreased perianal sensation
Lumbosacral abnormalities	Sacral dimple (above gluteal cleft or atypical appearance); tuft of hair, lipoma, or skin discoloration over the spine; signs suggestive of spinal dysraphism
Anatomic or structural Findings	Abnormal anal position; history of anorectal malformation repair; markedly tight or patulous anal sphincter
Laboratory abnormalities (when tested)	Positive celiac serology (suggestive of celiac disease); elevated inflammatory markers raise suspicion for inflammatory bowel disease

This table provides a concise, clinically practical overview to help pediatricians identify children who require further evaluation for organic causes.

Investigations (when and when not)

In most children with FI, particularly those with functional retentive or non-retentive forms, extensive investigations are not necessary. Diagnostic testing should be guided by the presence of red flags, atypical features, or poor response to initial management. The goal is to confirm the diagnosis, exclude organic pathology, and guide targeted therapy without subjecting children to unnecessary procedures[23].

Although frequently obtained, routine radiography, such as abdominal X-ray, is generally unnecessary in children with typical functional constipation and a clear clinical history. Its use may be justified only when the diagnosis is uncertain or when assessing fecal impaction in equivocal cases. Investigations should be selectively applied based on clinical suspicion or the presence of red flags[33]. Anorectal manometry can evaluate internal anal sphincter tone, the rectoanal inhibitory reflex, and rectal sensation, particularly in suspected neurogenic bowel or non-retentive FFI that is unresponsive to standard therapy[34]. Contrast enema is useful for visualizing colonic anatomy, stool distribution, and structural anomalies; it also helps plan surgical intervention if required. Magnetic resonance imaging (MRI) of the spine is recommended if neurologic deficits or cutaneous stigmata suggest spinal dysraphism or tethered cord syndrome[35]. Rectal biopsy is indicated when Hirschsprung disease is suspected (e.g., delayed meconium, explosive stool on DRE, chronic refractory constipation). Histopathological confirmation is essential[36]. Thyroid and celiac screening are considered when growth failure, chronic diarrhea, or other systemic features raise suspicion of endocrine or autoimmune disorders[37].

MANAGEMENT

FRFI

FRFI represents the most common subtype of FI in children and is typically secondary to chronic functional constipation with rectal dilatation and overflow soiling. Management must be structured, proactive, and sustained. The therapeutic goal is not merely the cessation of soiling, but also the restoration of normal rectal tone and sensation, the prevention of reaccumulation, and long-term behavioral normalization. Treatment is best conceptualized as four sequential but overlapping phases (Tables 3 and 4 and Figure 4)[38].

Figure 4 Integrated management algorithms for pediatric functional fecal incontinence retentive and non-retentive subtypes. This composite figure presents parallel, structured management pathways for the two major subtypes of pediatric functional fecal incontinence (FI). Functional retentive FI management follows a stepwise medical-behavioral approach beginning with education and demystification, mandatory disimpaction (preferably oral polyethylene glycol), and prolonged maintenance therapy combining osmotic laxatives, scheduled toileting, behavioral reinforcement, dietary optimization, and hydration. Long-term follow-up with gradual tapering is essential to prevent relapse. Non-retentive FI emphasizes behavioral and psychosocial interventions. First-line therapy includes structured toileting programs and positive reinforcement. Psychological assessment is recommended when comorbid behavioral or emotional disorders are suspected. Biofeedback therapy may be considered in selected cases. School-based accommodations are integral to sustained improvement. Together, these algorithms highlight the fundamental therapeutic distinction between constipation-driven overflow incontinence and behaviorally mediated non-retentive incontinence, underscoring the need for subtype-specific management strategies. PEG: Polyethylene glycol; ADHD: Attention-deficit/hyperactivity disorder.

Table 3 Recommended medication dosing in functional retentive fecal incontinence.

Medication	Phase	Dose	Maximum	Notes
Polyethylene glycol (PEG 3350)	Disimpaction	1-1.5 g/kg/day for 3-6 days	Up to 100 g/day	Mix in clear fluid
PEG 3350	Maintenance	0.4-0.8 g/kg/day	Titrate to effect	First-line
Lactulose	Maintenance (alternative)	1-2 mL/kg/day divided	-	May cause bloating
Magnesium hydroxide	Maintenance	1-3 mL/kg/day	-	Avoid in renal impairment
Sodium phosphate enema	Disimpaction (selected cases)	Age-based dosing	-	Avoid repeated use
Bisacodyl (oral)	Rescue	5-10 mg/day (age-based)	-	Short-term use only

Doses should be individualized according to response and tolerance. PEG: Polyethylene glycol.

Table 4 Comparative clinical and management characteristics of pediatric fecal incontinence subtypes.

Feature	FRFI	NRFI	Organic FI
Underlying mechanism	Chronic stool retention with overflow	Behavioral/defecation dysregulation without retention	Structural, neurologic, or postsurgical pathology
Primary pathophysiology	Rectal dilatation & reduced sensation	Functional/psychosocial factors	Impaired sphincter integrity or neural control
Disimpaction required	Yes (mandatory initial step)	No	Condition-specific
Role of laxatives	Essential (cornerstone of therapy)	Usually not indicated	Tailored to bowel physiology
Behavioral therapy	Adjunctive	First-line	Supportive
Psychological assessment	Selected cases	Frequently required	As indicated
Need for structured bowel program	During the maintenance phase	Behavioral toileting structure	Often lifelong
Surgical intervention	Rare	Not indicated	Frequently required in selected cases
Multidisciplinary involvement	Refractory cases	Persistent/complex cases	Standard of care
Duration of therapy	6-12 months or longer	Variable; behavior-dependent	Often long-term or lifelong

FI: Fecal incontinence; FRFI: Functional retentive fecal incontinence; NRFI: Non-retentive fecal incontinence.

Phase 1: Education and demystification (foundational phase): This phase determines adherence and long-term success with 3 main components. Parents and patients should be educated about the nature of the condition, that FRFI is common and treatable, and that it is a physiological consequence of stool retention. It is also important to remove guilt and blame by explicitly reassuring parents and the child that soiling is involuntary, avoiding punitive language, and properly addressing school-related stigma[39]. It is also important to explain the overflow mechanism, using simple physiology. For example, chronic stool withholding leads to rectal dilation and consequently decreased sensation. This allows the liquid stool to leak around impacted stool, while the child is often unaware of leakage. Visual explanation (rectal reservoir model) significantly improves compliance. This is particularly important as families who understand overflow pathophysiology demonstrate higher adherence and lower relapse rates[40].

Phase 2: Disimpaction (essential therapeutic reset): Disimpaction is a crucial first step and must be completed before initiating maintenance therapy, as inadequate clearance significantly increases the risk of relapse. Oral polyethylene glycol (PEG) is considered the first-line option due to its strong efficacy, favorable safety profile, and good tolerability. It is as effective as, and often superior to, rectal regimens, with the added advantages of being noninvasive and generally better accepted by children. Rectal Enemas are an alternative to PEG. It is reserved for severe impaction with abdominal pain, vomiting limiting oral therapy, failed oral disimpaction, or there is a need for rapid clearance. Repeated rectal interventions should be avoided unless clearly indicated[41,42].

Phase 3: Maintenance therapy (6-12 months minimum): Phase 3, the maintenance phase, lasts 6-12 months and aims to achieve soft, painless stools (Bristol type 4-5) daily while gradually restoring normal rectal tone. Maintenance therapy must begin immediately after successful disimpaction. It relies on several coordinated components[43]. Osmotic laxatives—particularly PEG—serve as the cornerstone of treatment. Structured toilet sitting is essential: Children are encouraged to sit for 5-10 minutes after meals to use the gastrocolic reflex, with their feet supported and their posture relaxed to optimize anorectal dynamics[44]. Behavioral reinforcement further supports adherence through positive reinforcement, stool diaries, and avoidance of punitive responses, with school involvement as needed. Dietary measures include optimizing fiber intake to approximately (age in year + 5-10) grams per day while avoiding excess fiber in children with large, hard stools, and emphasizing natural sources[45]. Adequate hydration appropriate for the child’s age is also vital, especially when using osmotic laxatives. Importantly, laxatives should not be discontinued prematurely once soiling ceases, as rectal size and sensation typically require 6-12 months to normalize, making premature tapering a common cause of relapse[46].

Phase 4: Long-term follow-up and relapse prevention: FRFI is a chronic condition with relapse rates reaching 30%-50%, making long-term follow-up essential. After symptom resolution, maintenance therapy should be continued for at least six months, then gradually tapered over several months rather than weeks. Ongoing monitoring of stool frequency and consistency is important for detecting early signs of recurrence[46]. Toilet routines should be reinforced during periods of life transition, such as school entry, travel, or illness, when relapses are common. During follow-up, the emergence of concerning features—including poor response despite adequate dosing, severe abdominal distension, growth failure, or neurologic abnormalities—should prompt re-evaluation for potential underlying organic pathology[47] (Table 5).

Table 5 Key clinical takeaways.

No.	Clinical takeaway
1	Disimpaction is non-negotiable
2	Maintenance therapy is long-term
3	Education determines success
4	Early tapering is the most common cause of relapse
5	Multidisciplinary approach improves refractory cases

NRFI

NRFI is characterized by inappropriate passage of stool without evidence of constipation or fecal retention. Unlike FRFI, children with NRFI have normal rectal diameter and stool burden, and overflow physiology is absent (Table 4). The underlying pathogenesis is multifactorial and commonly reflects behavioral dysregulation, psychosocial stressors, or dysfunctional toileting dynamics. Consequently, management is driven primarily by behavioral and psychological strategies rather than by pharmacologic therapy (Figure 4)[48].

Behavioral therapy (first-line management): Behavioral intervention is the first-line, cornerstone of treatment and should be initiated immediately after diagnosis. A structured toileting program is central to therapy and includes scheduled toilet sitting two to three times daily, preferably after meals, to take advantage of the gastrocolic reflex. Each session should last 5-10 minutes in a relaxed environment, with proper foot support to optimize the anorectal angle. Caregivers are encouraged to maintain a stool diary to track the frequency, timing, and circumstances of accidents, which can help identify contributing factors such as stress, school avoidance, or distraction[49]. Positive reinforcement is emphasized through reward systems for toilet-sitting compliance and accident-free days, while punitive approaches are strictly avoided. In NRFI, adherence to behavioral structure is far more critical than medication use; pharmacologic laxatives are not routinely indicated unless mild constipation coexists[50].

Psychological assessment: Psychological assessment is recommended in most children with NRFI, as comorbid emotional or behavioral disorders frequently coexist. Evaluation should be considered when there are features such as attention-deficit/hyperactivity disorder (ADHD), oppositional behaviors, anxiety, mood symptoms, school refusal, family stress, history of trauma or bullying, or persistent symptoms despite behavioral interventions. Ideally, assessment is performed by a pediatric psychologist or child psychiatrist. Depending on identified needs, therapeutic approaches may include cognitive behavioral therapy, parent management training, or family therapy. Addressing underlying psychosocial stressors often leads to significant improvement in continence outcomes[51,52].

Biofeedback therapy: Biofeedback therapy may be beneficial in selected cases, particularly when dyssynergic defecation or pelvic floor discoordination is suspected or when standard behavioral strategies fail. Biofeedback uses visual or auditory cues to enhance the child’s ability to relax the pelvic floor muscles, improve rectal sensory awareness, and coordinate defecation mechanics. Although evidence shows a modest benefit—particularly among motivated older children and adolescents—biofeedback is not considered a routine intervention for all NRFI patients[53].

School-based interventions: School environment often influences symptom persistence, making school-based interventions an essential component of management. Key accommodations include unrestricted bathroom access, scheduled toilet breaks, and privacy measures that support toileting without embarrassment. Discreet communication with teachers and collaboration with school nurses can further facilitate adherence to management plans. Failure to address school-related barriers is a common contributor to relapse or poor improvement[54].

Follow-up strategy in NRFI: Follow-up for NRFI should occur every 4-8 weeks initially to monitor accident frequency, assess behavioral adherence, and re-evaluate psychosocial factors. Escalation to multidisciplinary care is advised when symptoms do not improve after 3-6 months of appropriate management. Unlike FRFI, long-term laxative tapering is not required unless new-onset constipation develops secondarily[55].

Management of organic causes of FI

Organic FI in children arises from structural, neurologic, or postsurgical abnormalities that disrupt anorectal sensation, sphincter function, or colonic motility. Unlike FFI, these conditions require individualized, etiology-specific management and close multidisciplinary coordination among pediatric gastroenterologists, colorectal surgeons, urologists, rehabilitation specialists, psychologists, and continence nurses (Table 4 and Figure 5). The most prevalent organic etiologies in children include neurogenic bowel dysfunction and the long-term continence challenges observed after surgical repair of ARMs[56].

Figure 5 Management algorithm for organic fecal incontinence in children. The algorithm begins with confirmation of an organic etiology through clinical evaluation and targeted investigations. Management is guided by the dominant pathophysiologic pattern and initiated with a structured bowel program. If continence is achieved, maintenance therapy and longitudinal follow-up are recommended. Persistent incontinence warrants escalation to advanced interventions, including antegrade continence enema, surgical revision, sphincter reconstruction, or neuromodulation. Most patients require coordinated multidisciplinary care and long-term follow-up. ACE: Antegrade continence enema; ARM: Anorectal malformation; MRI: Magnetic resonance imaging; GI: Gastroenterology.

Neurogenic bowel dysfunction: Neurogenic bowel dysfunction results from impaired neural control of colonic propulsion and anal sphincter activity. It most commonly affects children with spina bifida, spinal cord injury, or tethered cord syndrome. The clinical phenotype varies depending on the level and extent of neurologic impairment, presenting as either hyperreflexic (spastic) bowel, characterized by increased sphincter tone and reflex-mediated stool retention, or areflexic (flaccid) bowel, associated with reduced anal sphincter tone and poor colonic propulsion[57]. Despite these differences, the overarching therapeutic goals remain consistent: Achieving predictable bowel evacuation, preventing constipation, FI, and megarectum, and promoting dignity, independence, and social participation. Because neurologic injury is permanent, the management of neurogenic bowel is inherently lifelong[58].

A structured bowel program is the first-line treatment for neurogenic bowel and must be tailored to the child’s age, type of dysfunction, developmental level, and family capacity (individualized bowel regimen). These programs typically include fixed timing for bowel emptying (daily or every other day), the use of rectal stimulants or suppositories to trigger evacuation, adjunctive oral laxatives when needed, and digital stimulation in selected cases to promote relaxation of the anal sphincter[59]. Proper toileting posture and adequate abdominal support further enhance successful emptying. Importantly, clinical experience consistently shows that the regimen's regularity and consistency are more influential than its specific components[60].

Transanal irrigation (TAI) is recommended when standard bowel programs do not achieve acceptable continence or when bowel movements remain unpredictable. By instilling large volumes of fluid into the rectum and distal colon, TAI facilitates reliable evacuation, improves continence rates, reduces abdominal bloating and distension, and significantly decreases the time and burden of bowel care. It is particularly effective in children with spina bifida and may delay or prevent the need for more invasive surgical interventions[61]. The antegrade continence enema (ACE), most commonly created using the Malone appendicostomy technique, is reserved for children with refractory FI who fail to achieve adequate control with conservative measures and TAI. It is particularly indicated when severe incontinence significantly impairs social functioning or when long-term independence in bowel management is a central therapeutic goal[62]. The procedure involves constructing a continent catheterizable channel—typically using the appendix—that permits antegrade colonic irrigation, enabling controlled and predictable bowel emptying. In appropriately selected patients, ACE markedly improves continence rates and overall quality of life. Given the surgical complexity and long-term management requirements, decision-making for ACE placement should be undertaken in collaboration with pediatric colorectal surgery and integrated into a structured follow-up plan to ensure sustained therapeutic success[63].

Post-surgical ARM: Children with a history of surgically repaired ARMs represent another major group affected by organic FI. Continence outcomes vary widely and depend on the type and level of malformation, sacral development, the presence of associated spinal anomalies, and the quality of the initial reconstruction. Although posterior sagittal anorectoplasty has substantially improved anatomic restoration, many children continue to experience incontinence, constipation, or dysmotility due to intrinsic sphincter deficiencies or altered rectal compliance. The management of post-surgical ARM-related FI requires individualized evaluation (based on anorectal anatomy, sphincter integrity, rectal compliance, and colonic motility) and a phenotype-driven approach[64,65].

Diagnostic assessment may involve contrast studies to evaluate colonic anatomy, anorectal manometry to assess sphincter function and rectal sensation, and spinal imaging when neurologic anomalies are suspected. Treatment strategies are tailored to the dominant physiologic problem: Laxative-based regimens for constipation-predominant patterns, enema-based programs for sphincter weakness, TAI for children with preserved colonic motility but inadequate sphincter control, and ACE procedures for refractory cases requiring high levels of continence support[66]. Redo surgery is reserved for children in whom postoperative anatomic defects, misplacement of the neoanus, or structural abnormalities are clearly contributing to incontinence[67].

Across all organic causes of pediatric FI, optimal outcomes depend on a coordinated multidisciplinary model of care. Integration of medical, surgical, rehabilitative, psychosocial, and nursing expertise ensures comprehensive assessment, tailored intervention, and long-term support that prioritizes continence, independence, and quality of life for affected children and their families[68].

Refractory cases

Despite adherence to structured bowel programs and optimized pharmacologic therapy, a subset of children continues to experience persistent FI. Refractory cases require escalation to advanced neuromodulatory, procedural, or multidisciplinary strategies tailored to the underlying pathophysiology and psychosocial context[69].

Biofeedback therapy (evidence level: II-III): Biofeedback is particularly beneficial in children with pelvic floor dyssynergia, impaired rectal sensation, or maladaptive defecatory dynamics. Using anorectal manometry-guided visual or auditory feedback, children are trained to improve coordination of the external anal sphincter and rectal awareness. Controlled pediatric studies demonstrate modest benefit in selected populations, especially those with documented dyssynergic defecation. However, routine use in uncomplicated FRFI is not consistently supported. Outcomes are strongly influenced by age, motivation, and adherence[70].

Sacral nerve stimulation (evidence level: II-III as pediatric data are limited): Sacral nerve stimulation is a minimally invasive neuromodulatory option for severe, refractory FI, particularly in selected cases of organic or neurogenic etiology. By modulating sacral nerve pathways (typically S3), sacral nerve stimulation may enhance sphincter function, rectal sensation, and colonic motility. While adult data are robust (level I-II), pediatric evidence consists mainly of prospective cohorts and case series demonstrating improved continence rates and quality of life measures. Long-term pediatric data remain limited, and therapy should be confined to specialized centers[71].

Botulinum toxin injection (evidence level: III): Intrasphincteric botulinum toxin may benefit selected children with internal anal sphincter hypertonicity, outlet obstruction, or non-relaxing sphincter physiology. By inducing chemical temporary relaxation of the sphincter, botulinum toxin facilitates rectal emptying and reduces overflow symptoms. Pediatric data derive primarily from observational studies and small case series. The therapeutic effect is transient and repeat injections may be required. Manometric confirmation of sphincter hypertonicity improves patient selection[72].

Multidisciplinary care (evidence level: II): Comprehensive multidisciplinary management is supported by observational and cohort data demonstrating improved adherence, continence outcomes, and psychosocial functioning. Refractory FI often reflects complex interactions between neuromuscular dysfunction, behavioral factors, and psychological stressors. Coordinated care involving pediatric gastroenterology, pediatric surgery, psychology, specialized continence nurses, and urology (when indicated) is considered best practice. Transition planning to adult services is recommended for adolescents with persistent disease[73].

Refractory FI represents a clinically heterogeneous group in whom standard medical and behavioral strategies are insufficient. Early identification of non-response and timely escalation to targeted neuromodulatory or procedural interventions are critical to preventing chronic psychosocial distress, school impairment, and reduced quality of life. Although advanced therapies can substantially improve continence outcomes in carefully selected patients, long-term prognosis is largely determined by the underlying etiology, adherence to structured programs, and the availability of sustained multidisciplinary support. Understanding these prognostic determinants is essential for counseling families and optimizing transition into adolescence and adulthood[74,75].

LONG-TERM PROGNOSIS

Long-term outcomes in pediatric FI vary substantially according to subtype, underlying pathophysiology, age at intervention, treatment adherence, and psychosocial context (Figure 6 and Table 6). Prognosis is generally favorable in functional forms with appropriate management, whereas organic etiologies often require sustained, individualized care into adolescence and adulthood[13].

Figure 6 Risk stratification model for persistence of pediatric fecal incontinence. Prognosis is influenced by etiology, severity of anorectal dysfunction, behavioral and neurologic comorbidities, treatment adherence, and access to multidisciplinary care. Children with functional retentive fecal incontinence who receive early intervention and maintain adherence typically demonstrate favorable long-term outcomes (low risk). Moderate risk is associated with delayed diagnosis, recurrent relapse, or behavioral comorbidity. High-risk patients—particularly those with organic etiologies, severe rectal dysfunction, neurologic impairment, or poor adherence—frequently require prolonged or lifelong bowel management. FRFI: Functional retentive fecal incontinence; ARM: Anorectal malformation.

Table 6 Prognostic factors influencing long-term outcomes in pediatric fecal incontinence.

Domain	Favorable prognostic factors	Unfavorable prognostic factors	Evidence level
Age at intervention	Early diagnosis and treatment initiation	Delayed presentation (> 2-3 years of symptoms)	I-II
Subtype (functional vs organic)	Functional retentive FI	Organic etiology (neurogenic, severe malformations)	II
Treatment adherence	Consistent adherence to the bowel program	Poor compliance/premature therapy discontinuation	I
Rectal function (FRFI)	Mild rectal dilatation, preserved sensation	Severe megarectum, reduced rectal sensation	II
Behavioral/psychological factors (NRFI)	Early psychological assessment and structured behavioral therapy	Comorbid ADHD, anxiety, and family dysfunction	II-III
Neurologic integrity (OFI)	Mild neurologic impairment	Severe spinal dysraphism or sphincter denervation	II-III
Access to multidisciplinary care	Coordinated GI-surgical-psychological support	Fragmented care or limited specialty access	II
Escalation when needed	Timely use of advanced therapies (e.g., ACE, neuromodulation)	Delayed referral in refractory cases	III
Transition planning	Structured transition to adult services	Loss to follow-up during adolescence	III

The table summarises clinical, behavioral, and structural factors associated with the long-term prognosis of pediatric fecal incontinence. Prognostic outcomes are strongly influenced by early intervention, adherence to therapy, and coordinated multidisciplinary care. FI: Fecal incontinence; FRFI: Functional retentive fecal incontinence; NRFI: Non-retentive fecal incontinence; ADHD: Attention-deficit/hyperactivity disorder; OFI: Organic fecal incontinence; ACE: Antegrade continence enema; GI: Gastroenterology.

FRFI (evidence level: I-II)

Longitudinal cohort studies and randomized trials demonstrate that most children with FRFI achieve continence with structured fecal disimpaction, maintenance laxative therapy, and behavioral modification[76]. Reported long-term recovery rates range from 60%-80% over several years, particularly when treatment adherence is maintained. However, relapses are common during periods of non-adherence or premature discontinuation of therapy. Poor prognostic indicators include severe rectal dilatation, delayed initiation of treatment, and significant psychosocial stressors. Early, aggressive management improves long-term bowel function and reduces the risk of recurrence[77].

NRFI (evidence level: II-III)

Prognosis in NRFI is more variable and closely linked to behavioral and psychological factors. While some children achieve spontaneous resolution with maturation, others require prolonged behavioral therapy and psychological support. Outcomes are strongly influenced by comorbid conditions such as ADHD, anxiety, or family dysfunction. Structured behavioral interventions are associated with improved continence and social functioning, although high-quality randomized data remain limited. Early psychological assessment enhances long-term outcomes[38].

Organic FI (evidence level: II-III)

In children with organic etiologies (e.g., neurogenic bowel, ARMs), long-term prognosis depends on the severity of anatomic or neurologic impairment. Many patients require ongoing structured bowel programs, TAI, or ACE procedures. Surgical reconstruction and neuromodulation may improve continence, yet complete normalization is not universally achievable. Lifelong bowel management is frequently necessary. Multidisciplinary follow-up significantly improves functional independence and quality of life metrics[1,78].

Psychosocial and quality of life outcomes (evidence level: II)

Untreated or persistent FI is associated with reduced self-esteem, social withdrawal, school absenteeism, and family stress. Studies consistently demonstrate that successful bowel management correlates with marked improvements in psychological well-being and social integration. Early recognition and integrated psychosocial support mitigate long-term emotional sequelae[79,80].

Transition to adult care (evidence level: III)

Adolescents with persistent symptoms, particularly those with organic etiologies, require structured transition planning to adult gastroenterology or colorectal services. Transition programs improve adherence, self-management skills, and continuity of care. A lack of coordination in the transition is associated with treatment interruptions and symptom recurrence. Overall, FFI carries a favorable long-term outlook when managed early and consistently. In contrast, organic causes often necessitate sustained therapeutic engagement and multidisciplinary oversight. Across all subtypes, prognosis improves with early intervention, individualized therapy, psychosocial support, and a structured transition to adult care[81,82].

PSYCHOSOCIAL IMPACT AND FAMILY COUNSELING

FI in children extends beyond a gastrointestinal disorder and represents a significant psychosocial condition with potential long-term emotional and social consequences. The visibility, stigma, and unpredictability of symptoms may profoundly affect a child’s self-esteem, peer relationships, academic performance, and family dynamics. Early recognition and structured psychosocial intervention are integral components of comprehensive management (Figure 7 and Table 7)[52].

Figure 7 Conceptual model of psychosocial impact in pediatric fecal incontinence. Pediatric fecal incontinence generates core stressors related to unpredictability, stigma, and chronic treatment demands. These stressors affect the child (self-esteem, anxiety, social withdrawal), school functioning (avoidance, absenteeism, academic impairment), and family dynamics (parental frustration, conflict, caregiver burnout). Without intervention, these factors may create a self-perpetuating psychosocial cycle that worsens adherence and symptom persistence. Early multidisciplinary intervention interrupts this cycle, improving psychological well-being, social integration, and overall quality of life.

Table 7 Practical family counseling framework in pediatric fecal incontinence.

Counseling domain	Key actions	Clinical rationale
Normalize and de-stigmatize	Explain FI as a medical condition; emphasize bowel physiology; reassure regarding treatability	Reduces shame, blame, and punitive responses
Set realistic expectations	Clarify need for months of therapy; discuss relapse risk; define measurable goals	Improves adherence and prevents premature discontinuation
Positive behavioral strategies	Avoid punishment; implement scheduled toileting; use reward systems for adherence; maintain neutral responses to accidents	Reinforces constructive behavior and reduces anxiety-related worsening
Address psychosocial concerns	Screen for anxiety/depression; assess school avoidance; facilitate teacher communication; encourage social participation	Prevents long-term emotional and social sequelae
Strengthen treatment adherence	Provide written bowel plans; schedule regular follow-up; reinforce medication compliance; encourage parental consistency	Strongly associated with favorable long-term prognosis
Escalation criteria	Persistent symptoms despite adherence; significant distress; family conflict; poor response to standard therapy	Ensures timely referral for multidisciplinary intervention

The table summarizes the structured family counseling framework designed to improve adherence, reduce psychosocial burden, and optimize long-term outcomes in pediatric fecal incontinence. FI: Fecal incontinence.

School avoidance and academic impairment (evidence level: II)

Children with FI frequently experience embarrassment related to odor, soiling episodes, and fear of public accidents. These concerns may lead to school avoidance, reduced classroom participation, and concentration difficulties. Recurrent absenteeism has been documented in both functional and organic forms of FI. Proactive communication with school personnel, individualized toileting plans, and discreet bathroom access can significantly mitigate academic disruption[1].

Social isolation and peer stigmatization (evidence level: II)

Peer relationships are particularly vulnerable in school-aged children and adolescents with persistent FI. Fear of ridicule may lead to withdrawal from social activities, sports, sleepovers, and extracurricular activities. Social isolation can perpetuate anxiety and depressive symptoms, further exacerbating bowel dysfunction through stress-related mechanisms. Structured counseling and reassurance about the condition's medical nature are essential for restoring social confidence[83].

Parental frustration and family dynamics (evidence level: II-III)

Parents often experience frustration, guilt, or misconceptions regarding intentional behavior, particularly in NRFI. Recurrent soiling episodes may generate family conflict, punitive responses, or inconsistent adherence to bowel programs. Education is critical to reframe FI as a neuro-gastrointestinal disorder rather than a behavioral fault. Clear explanation of pathophysiology, realistic timelines for improvement, and structured management plans improve parental confidence and therapeutic adherence[80,84].

Mental health comorbidities (evidence level: II)

Children with FI exhibit higher rates of anxiety, depression, ADHD, and oppositional behaviors compared with unaffected peers. Psychological distress may both result from and contribute to symptom persistence. Early screening for mental health comorbidities and timely referral to psychology services improve long-term outcomes and quality of life measures[85,86].

Multidisciplinary approach to psychosocial care

Optimal management of FI requires coordinated multidisciplinary collaboration[87]: (1) Pediatrician: First-line identification, family education, growth monitoring, and coordination of care; (2) Gastroenterologist: Diagnostic clarification, structured bowel program design, and escalation strategies; (3) Psychologist: Behavioral therapy, cognitive restructuring, anxiety management, and coping skill development; and (4) Pediatric surgeon: Evaluation and management of structural or refractory organic etiologies.

Integrated care models are associated with improved adherence, lower relapse rates, and better psychosocial adjustment than fragmented care approaches.

Psychosocial burden is a central determinant of quality of life in pediatric FI. Addressing emotional distress, family dynamics, and school integration is not ancillary but fundamental to successful long-term management. Early, coordinated, multidisciplinary intervention substantially improves both continence outcomes and psychosocial well-being[88].

FI IN SPECIAL POPULATIONS

FI presents unique diagnostic and therapeutic challenges in children with neurodevelopmental disorders or structural postoperative conditions. In these populations, symptom expressions, treatment adherence, behavioral dynamics, and long-term prognosis may differ substantially from those of typically developing children. Individualized, multidisciplinary strategies are essential (Table 8 and Figure 8)[1].

Figure 8 Tailored management algorithm for fecal incontinence in children with neurodevelopmental disorders. Management begins with confirmation of fecal incontinence subtype and assessment of cognitive and behavioral factors. Standard medical therapy is optimized according to pathophysiology, followed by neurodevelopmentally adapted behavioral strategies. Children with autism spectrum disorder benefit from visual supports and sensory desensitization, whereas those with attention-deficit/hyperactivity disorder (ADHD) require structured reminders and optimization of ADHD treatment. Developmental delay necessitates individualized, caregiver-led programs. Persistent symptoms warrant escalation to behavioral therapy, psychological support, or advanced bowel management within a multidisciplinary framework. FI: Fecal incontinence; ASD: Autism spectrum disorder; ADHD: Attention-deficit/hyperactivity disorder; FRFI: Functional retentive fecal incontinence; NRFI: Non-retentive fecal incontinence; GI: Gastroenterology.

Table 8 Clinical considerations and management adaptations in special populations with pediatric fecal incontinence.

Population	Key contributing factors	Common clinical challenges	Management adaptations	Prognostic considerations	Evidence level
ASD	Sensory hypersensitivity, rigid behaviors, & communication deficits	Toilet refusal, resistance to routine, anxiety-related withholding	Visual schedules, social stories, structured reinforcement, gradual desensitization, caregiver training	Variable; improves with structured behavioral adaptation and developmental support	II-III
ADHD	Impulsivity, distractibility, poor interoception	Inconsistent toileting, poor adherence, forgetfulness	Timed reminders, simplified bowel programs, integration with ADHD treatment, and parental supervision	Favorable if ADHD symptoms are optimized and adherence improves	II
Developmental delay/intellectual disability	Delayed toileting acquisition, cognitive limitations	Difficulty understanding toileting cues, motor coordination issues	Developmentally appropriate goals, structured routines, long-term reinforcement, caregiver-led programs	May require prolonged support; continence goals individualized	II-III
Postoperative anorectal malformation/Hirschsprung disease	Sphincter dysfunction, dysmotility, altered rectal sensation	Persistent incontinence despite surgery, constipation or hypermotility	Structured bowel management, transanal irrigation, ACE, long-term colorectal follow-up	Often chronic; long-term multidisciplinary management required	II-III

The table provides a comparative overview of clinical features, management adaptations, and prognostic considerations in special pediatric populations with fecal incontinence. ASD: Autism spectrum disorder; ADHD: Attention-deficit/hyperactivity disorder; ACE: Antegrade continence enema.

Autism spectrum disorder (evidence level: II-III)

Children with autism spectrum disorder frequently exhibit toileting difficulties related to sensory processing abnormalities, communication barriers, rigid behaviors, and anxiety. Stool withholding, resistance to toileting routines, and heightened sensitivity to bathroom environments are common. Behavioral interventions require adaptations, such as visual schedules, social stories, structured reinforcement systems, and caregiver training. Gradual desensitization and predictable routines improve adherence. Collaboration with developmental specialists enhances outcomes[89].

ADHD (evidence level: II)

Children with ADHD are at increased risk of both functional constipation and NRFI due to impulsivity, distractibility, and poor interoceptive awareness. Treatment non-adherence is a major barrier. Structured reminders, simplified bowel programs, and integration of behavioral therapy with ADHD management improve continence outcomes. Optimization of ADHD pharmacotherapy may indirectly enhance bowel program compliance[85].

Developmental delay and intellectual disability (evidence level: II-III)

Children with global developmental delay or intellectual disability often experience delayed acquisition of toileting skills. Impaired communication, limited cognitive flexibility, and motor coordination challenges may complicate training. Realistic developmental expectations are critical. Management should emphasize structured routines, caregiver education, and long-term behavioral reinforcement. In some cases, complete continence may not be achievable, and goals shift toward improved hygiene and social participation[90].

Postoperative ARM and Hirschsprung disease patients (evidence level: II-III)

Children following surgical correction of ARMs or Hirschsprung disease frequently experience persistent FI due to sphincter dysfunction, impaired sensation, dysmotility, or pelvic floor abnormalities. Many require lifelong structured bowel programs, TAI, or ACE. Early implementation of bowel management protocols improves continence rates and quality of life. Long-term follow-up in specialized colorectal centers is recommended, particularly during adolescence and transition to adult care[91].

Special populations require individualized assessment that integrates neurodevelopmental status, behavioral capacity, and structural considerations. Treatment goals may vary from full continence to functional social independence. Early multidisciplinary coordination—incorporating pediatricians, gastroenterologists, psychologists, surgeons, and developmental specialists—optimizes both medical and psychosocial outcomes[92].

Global health and resource-limited settings considerations

An important consideration in the management of pediatric FI is its applicability across diverse healthcare settings, particularly in low- and middle-income countries where access to specialized pediatric gastroenterology services may be limited. In such contexts, delayed diagnosis, limited availability of diagnostic tools (e.g., anorectal manometry, MRI), and restricted access to advanced therapies can hinder optimal care[93]. Simplified, algorithm-based approaches that rely on detailed clinical evaluation, caregiver education, and low-cost interventions—such as structured toileting routines, dietary modifications, and widely available osmotic laxatives—can provide effective first-line management. Task-sharing models involving primary care physicians and community health workers, combined with culturally sensitive counseling, may improve adherence and reduce stigma. Incorporating locally adaptable strategies is essential to ensure equitable implementation of evidence-based care and to address global disparities in pediatric continence management[94].

EMERGING CONCEPTS AND FUTURE DIRECTIONS

Advances in neuro-gastroenterology, microbiome science, digital health, and neuromodulation are reshaping the understanding and management of pediatric FI. Emerging research suggests that future therapeutic strategies will increasingly integrate biologic, behavioral, and technological approaches within personalized care frameworks[95].

The gut-brain axis: Evidence level: II (pediatric data evolving)

The bidirectional communication between the central nervous system and the enteric nervous system plays a pivotal role in bowel motility, visceral sensation, and the regulation of continence. Dysregulation of the gut-brain axis may contribute to altered rectal sensitivity, stress-related stool withholding, and behavioral components of FI. Functional neuroimaging and autonomic studies suggest that emotional stress can exacerbate colonic dysmotility and impair sphincter coordination. Future therapies may incorporate targeted psychological modulation, stress-reduction protocols, and neurocognitive interventions as integral components of bowel management[96].

Microbiome involvement: Evidence level: II-III

Alterations in gut microbial composition have been associated with functional constipation and disordered motility in children. Microbiome-mediated mechanisms may influence stool consistency, colonic transit, mucosal immunity, and gut-brain signaling. Although causality remains under investigation, modulation through dietary intervention, prebiotics, probiotics, and synbiotics represents a promising adjunctive strategy. Large-scale pediatric trials are needed to determine whether microbiome-targeted therapies can sustainably improve continence outcomes[97].

Digital behavioral therapy applications: Evidence level: II (limited pediatric FI-specific data)

Mobile health platforms and digital applications offer structured toileting reminders, adherence tracking, gamified reward systems, and telemonitoring. Digital tools may enhance engagement, particularly in children with ADHD or behavioral dysregulation. Remote monitoring can facilitate early identification of non-adherence and reduce relapse rates. Integration of digital behavioral therapy with conventional bowel programs represents a scalable, cost-effective future direction[98,99].

Advances in neuromodulation: Evidence level: II-III

Emerging neuro-modulatory techniques—including refined sacral nerve stimulation protocols, non-invasive transcutaneous electrical stimulation, and potential cortical modulation approaches—aim to optimize sphincter control and colonic motility. While pediatric evidence remains limited, technological refinement and improved patient selection criteria may expand applicability. Long-term safety and durability data remain essential research priorities[100].

Personalized bowel management programs: Evidence level: III (conceptual and early clinical models)

Future care models are shifting toward individualized bowel programs based on phenotype, rectal function testing, neurodevelopmental profile, psychosocial risk stratification, and possibly microbiome signatures. Integration of predictive analytics and digital monitoring may allow dynamic adjustment of therapy. Personalized strategies are particularly relevant for refractories and special populations.

Key research questions

This review identifies several unresolved research questions that remain critical to advancing the field of pediatric FI. Key areas requiring further investigation include identifying optimal biomarkers that reliably predict treatment response across FI subtypes, assessing the potential of microbiome-targeted therapies to achieve sustained clinical improvement, and evaluating the long-term efficacy and safety of neuromodulation techniques in children. Additionally, an important future direction involves determining how digital health tools can be effectively integrated into routine clinical care to enhance adherence and improve overall treatment outcomes.

Future research priorities

Long-term prospective outcome studies stratified by subtype: (1) Standardized definitions of refractory FI; (2) Microbiome-intervention randomized trials; (3) Pediatric neuromodulation registries; (4) Digital health validation studies; and (5) Biomarker-driven risk stratification models.

The future of pediatric FI management lies in biologically informed, technologically supported, and psychologically integrated care. Advancing from symptom control toward precision bowel management may improve both continence and quality of life outcomes[101].

LIMITATIONS OF CURRENT EVIDENCE

Despite substantial advances in the understanding and management of pediatric FI, the current evidence base remains constrained by methodological and structural limitations. These gaps complicate the interpretation of therapeutic efficacy, limit generalizability, and hinder the development of standardized clinical guidelines.

Heterogeneity of clinical trials

Studies evaluating treatment strategies for pediatric FI exhibit considerable heterogeneity in study design, patient selection, diagnostic criteria, and therapeutic protocols. Functional, retentive, non-retentive, and organic etiologies are often grouped together, obscuring subtype-specific outcomes. Variability in age ranges, symptom duration, and baseline severity further complicates cross-study comparisons. This heterogeneity limits the ability to perform robust meta-analyses and develop unified treatment algorithms.

Lack of long-term RCTs

While short- to intermediate-term outcomes are relatively well described, high-quality long-term RCTs remain scarce. Many interventions—particularly behavioral programs, neuromodulation, and advanced bowel management strategies—lack durability data beyond 1-2 years. Longitudinal studies are essential for evaluating sustained continence, relapse rates, psychosocial outcomes, and transitions into adulthood.

Limited pediatric neuromodulation data

Although sacral nerve stimulation and other neuro-modulatory techniques demonstrate promising results, pediatric data are primarily derived from small cohort studies and case series. Standardized selection criteria, optimal stimulation parameters, and long-term safety profiles remain incompletely defined. Comparative effectiveness studies between neuromodulation and established bowel management programs are particularly needed.

Variability in outcome measures

Outcome assessment in pediatric FI lacks standardization. Studies report varying frequencies of soiling episodes, continence rates, stool consistency, quality of life indices, or caregiver-reported satisfaction. Inconsistent definitions of “treatment success” and “refractory disease” impede data synthesis. Development of validated, universally accepted pediatric FI outcome measures—including psychosocial and functional endpoints—is a critical research priority.

Collectively, these limitations underscore the need for standardized diagnostic criteria, harmonized outcome metrics, multicenter pediatric RCTs with long-term follow-up, and subtype-specific research frameworks. Addressing these gaps will facilitate precision-based care and evidence-driven clinical guidelines.

CLINICAL GAPS ADDRESSED BY THIS REVIEW

This review addresses several persistent challenges in pediatric FI by highlighting key clinical gaps and offering practical solutions. These gaps include the absence of a standardized, clinically applicable diagnostic and management algorithm; inconsistent differentiation among functional subtypes, which often leads to inappropriate treatment choices; and the frequent under-recognition of psychosocial and neurodevelopmental contributors that significantly influence outcomes. Additionally, emerging concepts—such as the gut-brain axis, microbiome influences, and digital therapeutic tools—remain insufficiently integrated into routine clinical practice. By presenting structured diagnostic and management algorithms, practical counseling frameworks, and tailored strategies for special populations, this review aims to enhance diagnostic accuracy, improve treatment adherence, and support sustained long-term outcomes.

CONCLUSION

This review highlights clinically actionable insights, including the differential therapeutic response between functional subtypes, the critical role of early structured intervention, and the necessity for developmentally adapted strategies in special populations. It also emphasizes that psychosocial burden is not merely a consequence but a key determinant of treatment outcomes, requiring integrated management. Contemporary understanding emphasizes that successful management requires accurate subtype differentiation, structured bowel programs, and individualized therapeutic escalation when necessary. FRFI generally carries a favorable prognosis when early, sustained medical and behavioral strategies are implemented. Non-retentive forms demand targeted psychological and behavioral interventions, while organic etiologies often necessitate long-term multidisciplinary care and advanced procedural strategies. Recognition of special populations—including children with neurodevelopmental disorders and postoperative anorectal conditions—highlights the need for tailored management approaches. Emerging insights into the gut-brain axis, microbiome interactions, neuromodulation, and digital behavioral platforms signal a shift toward biologically informed and technologically supported precision care. However, the current evidence base remains limited by heterogeneous methodologies, insufficient long-term randomized data, and variability in outcome measures. Ultimately, optimal outcomes in pediatric FI depend not only on physiologic correction but also on psychosocial support, family education, and coordinated multidisciplinary collaboration. Advancing research standardization and embracing personalized care models will be essential to improving both continence and holistic well-being in affected children. This work provides a practical, algorithm-driven framework that can be readily implemented in both primary and specialized care settings. By translating complex pathophysiological and behavioral concepts into structured clinical pathways, it has the potential to improve early diagnosis, standardize management, reduce unnecessary investigations, and enhance long-term continence and quality of life outcomes.

ACKNOWLEDGEMENTS

We thank the anonymous referees for their valuable suggestions.